Genomic Profiling and Precision Oncology: Cancer/Tumor Profiling Market to Reach USD 35.46 Billion by 2034
Cancer is not a single disease. Two patients with the same type of cancer can have tumors with very different genetic and molecular characteristics, and those differences can determine which treatments will work. Understanding these characteristics is the foundation of precision oncology. Through genomic profiling and other molecular tests, doctors can match patients with targeted therapies and...
0 Commenti 0 condivisioni 7 Views 0 Anteprima
AC Mingle https://acmingle.com